Current lab members
My current scientific interest is to develop ways to wrest biological meaning from genetic studies of immune-mediated and seizure-related diseases. My job is to make sure everyone else in the group has the opportunity to do the best science possible in this sphere. As a reward, I’m allowed to watch, and occasionally participate, in great projects.
I studied biochemistry at Imperial College London, and received my PhD from UNSW in Sydney, Australia, for work on gene expression genetics with Peter Little. I then joined Mark Daly at MGH and the Broad Institute in Boston as a post-doc, where I co-lead several GWAS studies on diverse traits. If I had spare time I’d be interested in french cooking, street photography, fly fishing and modern greek literature.
Parisa joins our group from Ryan Brinkman’s lab at the BC Cancer Agency, where she specialized in flow cytometry data analysis and was instrumental in developing SamSPECTRAL. She leads our projects to integrate DNase I hypersensitivity data across cell types with genetic data to find disease pathways active in relevant tissues.
Klementy completed his doctoral studies at the Karolinska Insitutet in Stockholm, Sweden, on gene-gene interactions in rheumatoid arthritis. He now leads our project to uncover patient subsets in MS.
Hanna joins us after undergraduate studies in Biology at Berea College. Her project is to characterize changes to genome regulation due to differing amounts of NFkB activation.
Alisha is our main point of sanity. When she isn't shepherding grant submissions or scheduling meetings, she can be found roaming the highways and byways of Connecticut on a very, very large motorbike.
Kevin is currently studying math and philosophy at Yale College. His research project is to adapt our network search framework, PINTS, to a tool to detect interacting pathogenic genes in heterogeneous Mendelian diseases.
Postgraduate associate 2015-2017
Noah led data analytic projects to map genetic determinants of vaccine response, and to map shared genetic effects across multiple autoimmune diseases. He is now a graduate student at Harvard.
Postdoctoral Fellow 2011-2014
JinMyung used his background in particle physics to develop PINTS, our network searching framework, and used it to show that genes intolerant of mutation in the human lineage form a large interacting network expressed in early fetal brain development. He is now an Associate Research Scientist in the Department of Neurobiology, Yale School of Medicine.
Postgraduate Associate 2013-2014
Abhinay analyzed a genetic study of cellular responses to stimulus and developed a pipeline to allow our colleagues to conveniently look up those results for experimental followup. He is now studying medicine at Nova Southeastern University, FL.
Postdoctoral Fellow 2010-2012
As part of her research sabbatical, Barbara initiated a multi-center project to recruit and profile new-onset patients with a variety of autoimmune diseases. She has now returned to neurology practice in Munich, Germany.
Visiting Scientist 2010-2012
Michinori came for an extended sabbatical to learn how to analyze genome-wide association studies. He is a Research Scientist at Daiichi-Sankyo in Kobe, Japan.
Postdoctoral Fellow 2012-2015
Mitja lead our project for the International MS Genetics Consortium, looking for low-frequency coding variation associated to MS risk in >75,000 samples. He is now a Technical Development Scientist at Lek Pharmaceuticals in Ljubljana, Slovenia.
Postdoctoral Fellow 2012-2015
Arpita ran a six-center effort to collect blood samples from people newly diagnosed with a variety of autoimmune diseases. She is now a clinical trial manager at Oticon Medical, Gothenburg, Sweden.
Postdoctoral associate 2014-2015
Athena joined us briefly to work on shared effects across autoimmune diseases. She is now the Director of Engagement at the Center for Computational Science at the University of Miami.
Postgraduate Associate 2014-2015
Alex joined us after graduating from Boston College and drove the early phase of our GWAS/eQTL overlap project. After a stint as a quantitative analyst at Cogo Labs, she is now an associate quantitative specialist at Fidelity Investments.